Clinical Reports

Clinical Experience Reports

 

Because of the specific region availability, CardioCel® is approved/cleared for sale in Europe, the US, Canada, Hong Kong, Malaysia, Singapore, New Zealand and Middle East and North Africa Region. CardioCel® is also available under the special access scheme in Australia and other select countries.

CardioCel® is currently used by leading heart centres around the world and has been implanted in thousands of patients to date.

VascuCel® is approved/cleared for sale in the US only. For more information on VascuCel, please contact us here.

Our Infusion products are only available for purchase in Australia and New Zealand.

Interested to know more of our Products and Services, click here and choose the correct region.